同益中(688722.SH):人民幣貶值有利於公司出口業務拓展和增加匯兑收益
格隆匯2月6日丨同益中(688722.SH)在投資者互動平台表示,石油價格對公司成本影響不大;公司國內外主要競爭對手有荷蘭DSM(現被美國埃萬特收購)、美國Honeywell、日本東洋紡、九州星際、南山智尚、恒輝安防等企業;公司出口業務主要以美元進行結算,在不考慮其他因素的情況下,人民幣貶值有利於公司出口業務拓展和增加匯兑收益;公司控股股東、實際控制人全力支持同益中打造高分子新材料整合平台,持續推進同益中做大做優做強。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.